
BioPerfectus is a molecular diagnostics company serving clinical laboratories globally with in vitro PCR kits, extraction systems, and qPCR instruments.
bioperfectus.comCrawled Nov 9, 2026
Review HPV & Cervical Cancer Screening Solution for in vitro diagnostics and molecular testing, including diagnostic assays, PCR equipment and integrated laboratory workflows.
Review Influenza Total Solution for in vitro diagnostics and molecular testing, including diagnostic assays, PCR equipment and integrated laboratory workflows.
Review STI Asymptomatic Screening Solution for in vitro diagnostics and molecular testing, including diagnostic assays, PCR equipment and integrated laboratory workflows.
The 2025 ASCCP guidelines outline managing positive HPV test results using extended genotyping, linking HPV types to cervical cancer risk and clinical decisions based on FDA-approved assays.
West Africa faces multi-lineage mpox circulation, with updates on molecular diagnostics, PCR testing, and laboratory solutions.
Bioperfectus offers rapid, accurate diagnostics for dengue, malaria, Zika, and chikungunya during seasonal outbreaks.
Bioperfectus showcased molecular diagnostics, PCR kits, qPCR instruments, and in vitro diagnostic solutions at its 1st Distributors Conference & New Product Launch 2021.
Bioperfectus presented molecular diagnostics, PCR kits, qPCR instruments, and in vitro diagnostic solutions at the AACC 2020 digital press conference.
Bioperfectus announced its 2nd Global Distributors Conference, highlighting molecular diagnostics, PCR kits, qPCR instruments, and in vitro diagnostic solutions.
Download Bioperfectus PCR kit leaflets, product catalogues, publications, videos and promotional materials for molecular diagnostics and IVD solutions.
Bioperfectus offers careers in China across sales, product management, and technical support for molecular diagnostics.
Explore PCR supplies, PCR kits, qPCR instruments and in vitro diagnostic solutions. Accelerate molecular testing with reliable products and expert support.
BioPerfectus launches the **STAX-12A**, a benchtop molecular diagnostic system integrating nucleic acid extraction, PCR amplification, fluorescence detection, and automated result interpretation into a single instrument. The compact, automated platform enables flexible and streamlined workflows for molecular testing in laboratories. It supports customizable assay configurations to adapt to diverse diagnostic needs.
Nov 2026Yahoo FinanceNews article
BioPerfectus presents diagnostic tools targeting HPV detection and cervical cancer screening. The company also showcases solutions for sexually transmitted infections (STIs) and vector-borne diseases. These innovations aim to improve early disease identification and patient outcomes through advanced testing technologies.
Feb 2024Labmedica.comNews article
Bioperfectus presents its automated systems for extracting nucleic acids, targeting efficiency in molecular diagnostics. The solutions integrate into laboratory workflows, supporting high-throughput processing for research and clinical applications. The company highlights advancements in streamlining sample preparation for PCR and sequencing workflows.
Jul 2023Labmedica.comNews article
Bioperfectus introduces new MPXV detection kits designed to improve monkeypox virus identification and outbreak management. The kits aim to enhance diagnostic accuracy and response efficiency for healthcare providers. The company focuses on molecular diagnostics solutions to support public health efforts during the current outbreak.
Sep 2022Labmedica.comNews article